This report indicates the efficacy of anti-VEGF treatment in a patient with concurrent beta thalassemia and CNV, consistent with previous reports that considered anti-VEGF as a safe and effective treatment option for CNVs due to angioid streaks [9]. The gene discussed is VEGFA; the disease is Beta-thalassemia.